Continuation with apixaban treatment is associated with lower risk for hospitalization and medical costs among elderly patients.
Curr Med Res Opin
; 35(10): 1769-1776, 2019 10.
Article
in En
| MEDLINE
| ID: mdl-31120309
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrazoles
/
Pyridones
/
Atrial Fibrillation
/
Health Care Costs
Type of study:
Etiology_studies
/
Health_economic_evaluation
/
Observational_studies
/
Risk_factors_studies
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
Language:
En
Journal:
Curr Med Res Opin
Year:
2019
Type:
Article
Affiliation country:
United States